2020
DOI: 10.1038/s41598-020-72417-5
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of extracellular volume fraction by cardiac computed tomography for noninvasive assessment of myocardial fibrosis in hemodialysis patients

Abstract: Extent of myocardial fibrosis in hemodialysis patients has been associated with poor prognosis. Myocardial extracellular volume (ECV) quantification using contrast enhanced cardiac computed tomography (CT) is a novel method to determine extent of myocardial fibrosis. Cardiac CT-based myocardial ECV in hemodialysis patients with those of propensity-matched non-hemodialysis control subjects were compared. Twenty hemodialysis patients (mean age, 67.4 ± 9.6 years; 80% male) and 20 propensity-matched non-hemodialys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
3
0
11

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 38 publications
0
3
0
11
Order By: Relevance
“…Our results also confirmed a strong correlation of CT-ECV using iodine density maps from dual-layer spectral detector CT, with MRI-ECV demonstrating a small bias. Some recent studies have investigated the feasibility of CT-ECV in different cardiac diseases, including cardiac amyloidosis (22), hypertrophic cardiomyopathy (23), dilated cardiomyopathy (24), heart failure (7), and in hemodialysis patients (25). Ohta et al (24) evaluated CT-ECV in both nonischemic dilated cardiomyopathy patients and normal participants, and defined a threshold (a cutoff of 28.82%) to distinguish healthy myocardial tissue from dilated cardiomyopathy patients.…”
Section: A B Cmentioning
confidence: 99%
“…Our results also confirmed a strong correlation of CT-ECV using iodine density maps from dual-layer spectral detector CT, with MRI-ECV demonstrating a small bias. Some recent studies have investigated the feasibility of CT-ECV in different cardiac diseases, including cardiac amyloidosis (22), hypertrophic cardiomyopathy (23), dilated cardiomyopathy (24), heart failure (7), and in hemodialysis patients (25). Ohta et al (24) evaluated CT-ECV in both nonischemic dilated cardiomyopathy patients and normal participants, and defined a threshold (a cutoff of 28.82%) to distinguish healthy myocardial tissue from dilated cardiomyopathy patients.…”
Section: A B Cmentioning
confidence: 99%
“…Для изучения величины показателя ВММ для фиброза в сравнении со здоровым миокардом было отобрано 6 работ, опубликованных в период с 2016 по 2021 г. [20][21][22][23][24][25].…”
Section: сравнение вмм для фиброза и непораженного миокардаunclassified
“…Данные были представлены в процентном соотношении. Анализ миокарда проводился в соответствии с 16-сегментным делением Американской ассоциации сердца (American Heart Association) [20][21][22][23][24][25].…”
Section: сравнение вмм для фиброза и непораженного миокардаunclassified
See 2 more Smart Citations